The FDA has accepted Sobi’s sBLA for Gamifant for haemophagocytic lymphohistiocy...
At the American Society of Clinical Oncology (ASCO) Genitourinary Cancer Symposi...
Alltrna’s CEO Michelle Warner said that the approach allows for basket trials th...
Zevra will use the $150m to support the commercial launches of rare disease drug...
RedHill has signed an exclusive licensing agreement with Hyloris for the global ...
Organovo’s lead asset FXR314 will be investigated in a Phase II trial for inflam...
The US Food and Drug Administration (FDA) has granted breakthrough therapy desig...
The FDA has granted fast track designation to Pyxis oncology’s PYX-201 for the t...
Eli Lilly has announced plans to expand its domestic medicine production in the ...
In this issue: The surge in demand for radiopharmaecuticals, the potential affec...
Eikon’s lead candidate EIK1001 is being investigated for melanoma in combination...
The Phase III trial met the primary and secondary endpoints of reducing tics in ...
With a potential buyer not working out, Idorsia has adjusted an existing partner...
The US Food and Drug Administration (FDA) approved 126 innovator and biosimilar ...
MeiraGTx’s investigational gene therapy AAV-AIPL1 has improved the sight of 11 c...
Teva Pharmaceuticals and Alvotech have announced the US launch of Selarsdi (uste...
